V-Care Pharma Private Limited - Due diligence report

A 360° intelligence report on V-Care Pharma: trust score, financial health, credit view, compliance, directors, growth and distress signals …

2000-11-22 Rajkot, Gujarat Active Unlisted Active Compliant
Share
VP V-Care Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

V-Care Pharma — 360° Intelligence Report

Generated from MCA filings & public records
95/100
Trust Score
Low Risk

V-Care Pharma is assessed as Low Risk with a Trust Score of 95/100. V-Care Pharma is an active private limited indian non-government company incorporated in 2000, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. V-Care Pharma Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
95/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 3 satisfied (44.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Vijay Commercial Co-Operative Bank Ltd.1 48.0 cr
Vijay Commercial Co-Operative Bank Limited1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
HARESHKUMAR MANSUKHLAL JAGANI 01234567 Director 01/04/2018 6 yrs Approved
REKHABEN BHAVDIPBHAI UPADHAYAY 01234567 Director 01/04/2018 6 yrs Approved
BABULAL MOHANBHAI BHUVA 01234567 Director 01/04/2018 6 yrs Approved
VINODKUMAR LAXMANBHAI KACHHADIA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 3 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 85 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Net margin improved to 61%.
Operating for 25+ years.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence95/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment95/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view91/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
16 Aug 2021
Charge satisfied
Others
30 May 2020
Director appointed
HARESHKUMAR MANSUKHLAL JAGANI (Director)
Director appointed
REKHABEN BHAVDIPBHAI UPADHAYAY (Director)
15 Feb 2020
Director ceased
BHAVDIPBHAI RAMNIKLAL UPADHYAY
31 Mar 2016
Share transfer (FY 2016)
1500.00000000 shares to Mohanbhai Babulal
Share transfer (FY 2016)
800.00000000 shares to Ramniklal Bhavdipbhai
Share transfer (FY 2016)
200.00000000 shares to Mohanbhai Babulal
21 Mar 2016
Charge satisfied
Vijay Commercial Co-Operative Bank Ltd.
Charge satisfied
Vijay Commercial Co-Operative Bank Limited
14 Mar 2016
Charge created
Others - 30.00 Lakh
23 Jan 2012
Charge created
Vijay Commercial Co-Operative Bank Ltd. - 10.00 Lakh
16 Nov 2011
Director appointed
BABULAL MOHANBHAI BHUVA (Director)
12 Feb 2008
Charge created
Vijay Commercial Co-Operative Bank Limited - 4.00 Lakh
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
Debt-to-equity stands at 24% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 3 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Hydrotec Technologies India Private Limited U51909WB2012FTC183392 Kolkata, West Bengal, India
Dinils Adhesives Private Limited U99999MH1965PTC013108 Mumbai, Maharashtra, India
Lavina Exim Pvt.Ltd. U51909WB1995PTC070735 Kolkata, West Bengal, India
Deify Infrastructures Private Limited U45203MH1991PTC062494 Nagpur, Maharashtra, India
Classic Commotrade Private Limited U51109WB2008PTC121773 Kolkata, West Bengal, India
Dsh Technologies Private Limited U74999MH2018PTC306279 Indira Nagar, Nashik, Maharashtra, India
Gaurav Mining Equipments Private Limited U29230MH1989PTC051104 Nagpur, Maharashtra, India
Karvi Drugs Private Limited U24231UP2000PTC025586 Uttar Pradesh, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify V-Care Pharma before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of V-Care Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for V-Care Pharma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 95/100, distress signals and MSME payment-delay disclosures - know whether V-Care Pharma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for V-Care Pharma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is V-Care Pharma an active company?

V-Care Pharma has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is V-Care Pharma financially healthy?

V-Care Pharma has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with V-Care Pharma?

Its overall Trust Score is 95/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls V-Care Pharma?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does V-Care Pharma have loans or charges against its assets?

No open charges - all 3 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is V-Care Pharma up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to V-Care Pharma?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.